Cintas (CTAS) Receives a Hold From Morgan Stanley
Cintas Downgraded to Sell Amid Sluggish Organic Growth and Pricing Concerns
Barclays Remains a Buy on Cintas (CTAS)
Morgan Stanley Adjusts Price Target on Cintas to $195 From $202, Keeps Hold Rating
Goldman Sachs Maintains Buy on Cintas, Lowers Price Target to $211
UBS Maintains Buy on Cintas, Lowers Price Target to $218
RBC Capital Reiterates Sector Perform on Cintas, Maintains $215 Price Target
Wells Fargo Maintains Underweight on Cintas, Lowers Price Target to $184
Cintas Is Maintained at Neutral by Baird
Cintas Analyst Ratings
Stifel Cuts Price Target on Cintas to $189 From $214
Baird Cuts Price Target on Cintas to $200 From $209
RBC Capital Maintains Cintas(CTAS.US) With Hold Rating, Maintains Target Price $215
Cintas Analyst Ratings
Morgan Stanley Maintains Equal-Weight on Cintas, Raises Price Target to $202
Morgan Stanley Adjusts Price Target on Cintas to $202 From $185
Wells Fargo Maintains Cintas(CTAS.US) With Sell Rating, Maintains Target Price $191
Cintas Stock: Overvaluation Concerns Lead to Sell Rating by Jason Haas CFA
RBC Capital Sticks to Its Hold Rating for Cintas (CTAS)
Rollins Rated Equal Weight in New Coverage at Barclays